Literature DB >> 12972936

Lesion formation in radiofrequency surgery of the tongue base.

Boris A Stuck1, Julian Köpke, Joachim T Maurer, Thomas Verse, Andreas Eckert, Gregor Bran, Christoph Düber, Karl Hörmann.   

Abstract

OBJECTIVES: Temperature controlled radiofrequency volumetric tissue reduction (RFVTR) of the tongue base is a minimally invasive technique for the treatment of obstructive sleep apnea. But despite its widespread use, little is yet known about in vivo effects in humans. Such knowledge would be essential for evidence-based criteria in the selection of energy application.
METHODS: In a preparatory in vitro study, porcine tongues were preserved in growing medium. Lesions with different amounts of energy were applied, and maximum diameters were assessed. In the in vivo study, 11 patients were treated with RFVTR at the tongue base by employing different energy levels (800, 600, 400, or 200 J) on two application sites. Magnetic resonance imagery scans were performed 4 to 6, 8 to 10, and 24 hours after surgery. An inversion recovery technique was used to visualize the lesions.
RESULTS: RFVTR created lesions at the porcine tongue from 50 J and higher. Maximum lesion sizes were achieved with 400 J. In vivo, all the lesions were clearly visible in the postoperative scans. Lesion size increased with the amount of energy applied. Maximum diameters were created from 600 J and higher. Higher amounts of energy only resulted in a slight increase in lesion length.
CONCLUSIONS: The application of 600 J at 85 degrees C leads to optimal lesion sizes. Higher amounts of energy will not lead to a relevant increase in tissue necrosis. With regard to the time needed for application, 600 J appears to be the ideal adjustment for energy delivery in the treatment of the human tongue.

Entities:  

Mesh:

Year:  2003        PMID: 12972936     DOI: 10.1097/00005537-200309000-00030

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Bipolar radiofrequency induced thermotherapy of the tongue base: Its complications, acceptance and effectiveness under local anesthesia.

Authors:  Cindy den Herder; Dennis Kox; Harm van Tinteren; Nico de Vries
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-22       Impact factor: 2.503

2.  UPPP combined with radiofrequency thermotherapy of the tongue base for the treatment of obstructive sleep apnea syndrome.

Authors:  Emke van den Broek; Wietske Richard; Harm van Tinteren; Nico de Vries
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-03-18       Impact factor: 2.503

Review 3.  [Update on upper airway evaluation in obstructive sleep apnea].

Authors:  J T Maurer; B A Stuck
Journal:  HNO       Date:  2008-11       Impact factor: 1.284

4.  Theoretical approach towards increasing effectiveness of palatal surgery in obstructive sleep apnea: role for concomitant positional therapy?

Authors:  J P van Maanen; B I Witte; N de Vries
Journal:  Sleep Breath       Date:  2013-09-07       Impact factor: 2.816

5.  One stage multilevel surgery (uvulopalatopharyngoplasty, hyoid suspension, radiofrequent ablation of the tongue base with/without genioglossus advancement), in obstructive sleep apnea syndrome.

Authors:  Wietske Richard; Dennis Kox; Cindy den Herder; Harm van Tinteren; Nico de Vries
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-10-25       Impact factor: 2.503

6.  Complications of hyoid suspension in the treatment of obstructive sleep apnea syndrome.

Authors:  Wietske Richard; Ferdinand Timmer; Harm van Tinteren; Nico de Vries
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-18       Impact factor: 2.503

7.  Radiofrequency ablation in snoring surgery: local tissue effects and safety measures.

Authors:  Jagdeep Singh Virk; Gaurav Kumar; Dhafir Al-Okati; Bhik Kotecha
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-27       Impact factor: 2.503

8.  Exploration of the relationship between sleep position and isolated tongue base or multilevel surgery in obstructive sleep apnea.

Authors:  J P van Maanen; M J L Ravesloot; B I Witte; M Grijseels; N de Vries
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-03-20       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.